Literature DB >> 19760375

Incidence rate of pulmonary embolism in Germany: data from the federal statistical office.

K Kröger1, Ch Moerchel, Th Moysidis, F Santosa.   

Abstract

With the introduction of Diagnosis Related Groups (DRG) for reimbursement in 2003 detailed description of the prevalence of pulmonary embolism (PE) in hospitalized patients in Germany was possible for the first time. Thus we estimated the incidence rate of PE in Germany. Detailed lists of all PE coded as I26 performed in 2005, 2006 and 2007 were provided by the Federal Statistical Office. In addition age- and gender-adjusted incidence rates were calculated for all cases for which PEs were coded. In 2005 a total of 67,351, in 2006 a total of 69,234 and in 2007 a total of 71,223 PEs (I26.0) were coded either as principal or secondary diagnosis in German hospitals. 54-57% of all PEs were coded as principal diagnosis. Age- and gender adjusted incidence of PEs raised with increasing ages and were higher in males aged 30-49 and 50-69 years than in females within the same age groups. Up to 60% of all PE documented in females occurred within the 8th and 9th decade of life. Departments of Geriatric Medicine, Haematology and Oncology and Pneumology had the highest rates of intrahospital PEs documented as secondary diagnosis. The presented data are derived from the most reliable data base for the estimation of PE in Germany, and the analysis shows that PE is still a relevant problem. They do not give any information about the individual settings and preventability of PEs. An accompanying analysis of hospital and pre-hospital settings is mandatory to recognize possible strategies to prevent PEs more effectively.

Entities:  

Mesh:

Year:  2010        PMID: 19760375     DOI: 10.1007/s11239-009-0396-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  27 in total

1.  Estimated case fatality rate of pulmonary embolism, 1979 to 1998.

Authors:  Paul D Stein; Fadi Kayali; Ronald E Olson
Journal:  Am J Cardiol       Date:  2004-05-01       Impact factor: 2.778

2.  Fatal pulmonary embolism and stroke.

Authors:  Elias Skaf; Paul D Stein; Afzal Beemath; Julia Sanchez; Ronald E Olson
Journal:  Am J Cardiol       Date:  2006-04-27       Impact factor: 2.778

3.  Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

Authors:  Francesco Dentali; James D Douketis; Monica Gianni; Wendy Lim; Mark A Crowther
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

4.  Accuracy and epidemiological implications of the death certificate diagnosis of pulmonary embolism.

Authors:  S E Dismuke; R VanderZwaag
Journal:  J Chronic Dis       Date:  1984

5.  Decreasing mortality from pulmonary embolism in the United States, 1979-1996.

Authors:  D E Lilienfeld
Journal:  Int J Epidemiol       Date:  2000-06       Impact factor: 7.196

6.  Thromboprophylaxis and death after total hip replacement.

Authors:  D W Murray; A R Britton; C J Bulstrode
Journal:  J Bone Joint Surg Br       Date:  1996-11

7.  Venous thromboembolic disease: comparison of the diagnostic process in men and women.

Authors:  Paul D Stein; Russell D Hull; Kalpesh C Patel; Ronald E Olson; William A Ghali; Andrew K Alshab; Frederick A Meyers
Journal:  Arch Intern Med       Date:  2003-07-28

8.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Authors: 
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

10.  Venous thromboembolism in the outpatient setting.

Authors:  Frederick A Spencer; Darleen Lessard; Cathy Emery; George Reed; Robert J Goldberg
Journal:  Arch Intern Med       Date:  2007-07-23
View more
  6 in total

1.  A primary intravascular synovial sarcoma causing deep-vein thrombosis and pulmonary embolism in a 20-year-old woman.

Authors:  M Schreiner; W Sanad; B M Pfitzner; G Baumann; F Knebel
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

2.  Effectiveness and safety of thrombolytic therapy in elderly patients with pulmonary embolism.

Authors:  Göktürk İpek; Mehmet Baran Karataş; Tolga Onuk; Barış Güngör; Burcu Yüzbaş; Muhammed Keskin; Ozan Tanık; Ahmet Oz; Mert İlker Hayıroğlu; Osman Bolca
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

Review 3.  The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis.

Authors:  Xiao-Yu Zhou; Su-Qin Ben; Hong-Lin Chen; Song-Shi Ni
Journal:  Respir Res       Date:  2012-12-04

4.  Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia-A Retrospective Study.

Authors:  Daniel Chober; Bogusz Aksak-Wąs; Jolanta Niścigorska-Olsen; Małgorzata Niekrasz; Miłosz Parczewski
Journal:  Biomedicines       Date:  2022-07-02

Review 5.  Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Christophe Marti; Gregor John; Stavros Konstantinides; Christophe Combescure; Olivier Sanchez; Mareike Lankeit; Guy Meyer; Arnaud Perrier
Journal:  Eur Heart J       Date:  2014-06-10       Impact factor: 29.983

6.  Long-term outcomes in patients with acute pulmonary embolism after in-hospital treatment: study protocol of the prospective Lungenembolie Augsburg Studie (LEA study).

Authors:  Christa Meisinger; Jakob Linseisen; Inge Kirchberger; Wolfgang von Scheidt; Thomas M Berghaus
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.